Coleman Research Group’s Technology, Media & Telecom department highlights Synthetic trees and Twitter

Coleman Research Group’s Technology, Media & Telecom Group facilitates consultations between our clients (institutional investors) and leading technology professionals on a wide variety of topics including semiconductors, data storage and security, computer hardware and software, satellite system operators, telecom equipment, cable and wireless providers, and advertising spending.

Our TMT network spans technology industries across the globe and includes CTOs, CIOs, marketing and business development executives, engineers, buyers, and resellers.

********************************

'Synthetic tree' claims to catch carbon in the air

LONDON, England (CNN) -- Scientists in the United States are developing a "synthetic tree" capable of collecting carbon around 1,000 times faster than the real thing.

As the wind blows though plastic "leaves," the carbon is trapped in a chamber, compressed and stored as liquid carbon dioxide.

The technology is similar to that used to capture carbon from flue stacks at coal-fired power plants, but the difference is that the "synthetic tree" can catch carbon anytime, anywhere.

"Half of your emissions come from small, distributed sources where collection at the site is either impossible or impractical," said Professor Klaus Lackner, Ewing-Worzel Professor of Geophysics in the Department of Earth and Environmental Engineering at Columbia University.

********************************

Twitter message could be cyber criminal at work

(CNN) -- Cyber criminals are setting snares that move at the speed of news.

Panda Security, a Spain-based antivirus maker, has been monitoring an onslaught of links with malicious software, or "malware," on Twitter that tag hot topics such as the Air France crash, the NBA finals, "American Idol" runner-up Adam Lambert and the new iPhone.

"Cyber criminals have been targeting Twitter users by creating thousands of messages (tweets) embedded with words involving trending topics and malicious URLs," Sean-Paul Correll, a threat researcher for Panda Labs, wrote recently on a blog for the company.

********************************

To learn more about Coleman Research Group please visit the Coleman Research Group website or at any of the links below:

About Coleman Research Group
Coleman Research Group Testimonials
Coleman Research Group on LinkedIn
Coleman Research Group on Facebook
Coleman Research Group on Flickr
Coleman Research Group on Squidoo
Coleman Research Group on Namyz
Coleman Research Group on Twitter
Coleman Research Group on Review-Inc
Coleman Research Group Contact Us
Coleman Research Group on 800 Review
Coleman Research Group on Blogspot
Coleman Research Group on Jobster
Coleman Research Group's Knowledge Broker

Coleman Research Group’s Healthcare department highlights Cancer and HIV/AIDS treatments

Coleman Research Group’s Healthcare Team facilitates consultations between our clients (institutional investors) and leading healthcare professionals on a wide variety of topics including pharmaceuticals, biotechnology, clinical research, medical devices, healthcare providers, insurance, and regulatory issues.

Our Healthcare network spans technology industries across the globe and includes doctors, researchers, scientists, healthcare executives, consultants, and former regulatory officials.

********************************

Cancer spread to liver responds to experimental treatment

BALTIMORE, Maryland (CNN) -- When Linda Campbell of Lexington, North Carolina, started to lose her vision in winter 2000 she knew something was wrong. After a diagnosis of ocular melanoma, a rare cancer, she went through numerous treatments to save her eye. Despite one recurrence, by 2007 Campbell was pretty sure she had beaten the odds. That was until last year, when her doctors found lesions on her liver. Her melanoma had spread.

After an experimental cancer treatment, Linda Campbell has returned to work, with her dog Peanut." It was pretty devastating," she said.

Scans showed Campbell's liver was peppered with cancer. There were so many spots, they were impossible to count.

********************************

A generation born with HIV/AIDS defies the odds

No one expected them to live long.

A glass tree at the University of Miami commemorates those who died from complications of HIV/AIDS. Many of their peers succumbed to unusual infections by their first or second birthdays. They were living on borrowed time, it seemed.

While their friends' parents visited schools, these kids visited their parents' graves. When their classmates planned for the future, they often thought about death.

But those babies who were born with HIV/AIDS in the 1980s have defied initial expectations.

********************************

To learn more about Coleman Research Group please visit the Coleman Research Group website or at any of the links below:


About Coleman Research Group
Coleman Research Group Testimonials
Coleman Research Group on LinkedIn
Coleman Research Group on Facebook
Coleman Research Group on Flickr
Coleman Research Group on Squidoo
Coleman Research Group on Namyz
Coleman Research Group on Twitter
Coleman Research Group on Review-Inc
Coleman Research Group Contact Us
Coleman Research Group on 800 Review
Coleman Research Group on Blogspot
Coleman Research Group on Jobster
Coleman Research Group's Knowledge Broker

Coleman Research Group’s Business and Financial Services Group highlights Twitter and Google

Coleman Research Group’s Business and Financial Services Group facilitates consultations between our clients (institutional investors) and leading business and financial services professionals on a wide variety of topics including consumer credit trends, banking and investment services, insurance, residential and commercial real estate, student lending, and regulatory issues.

Our Business & Financial network includes an elite assembly of current and former CFOs and senior executives, accountants, former regulatory officials, academics, and top-level industry consultants.

********************************

Twitter Will Make Money With Sponsored Direct Messages

Twitter users should get ready for messages from companies bearing coupons and discounts, says a Twitter investor.

Todd Chaffee, an Institutional Venture Partners VC and Twitter board member, told the New York Times Twitter will make money allow companies to send users coupons and e-commerce links embedded in messages sent as automatic replies to questions like "What treadmill should I buy?,"

He said: “Commerce-based search businesses monetize extremely well, and if someone says, ‘What treadmill should I buy?’ you as the treadmill company want to be there. As people use Twitter to get trusted recommendations from friends and followers on what to buy, e-commerce navigation and payments will certainly play a role in Twitter monetization.”

********************************

The perks of marrying Google

NEW YORK (CNNMoney.com) -- When it comes to raising capital in the current economic environment, being married to a Google co-founder has its advantages.

Regulatory forms filed Thursday showed the internet search giant recently invested another $2.6 million in biotech firm 23andMe, which was co-founded in 2006 by Anne Wojcicki.

Wojcicki is married to Google co-founder Sergey Brin.

Google already has a $3.9 million stake in the company, which sells DNA analysis. It made that investment in 2007, shortly after Brin and Wojcicki were married.

"We believed the technology had promise the first time we invested and continue to believe that now," said Jane Penner, a Google spokeswoman.

********************************

To learn more about Coleman Research Group please visit the Coleman Research Group website or at any of the links below:

About Coleman Research Group
Coleman Research Group Testimonials
Coleman Research Group on LinkedIn
Coleman Research Group on Facebook
Coleman Research Group on Flickr
Coleman Research Group on Squidoo
Coleman Research Group on Namyz
Coleman Research Group on Twitter
Coleman Research Group on Review-Inc
Coleman Research Group Contact Us
Coleman Research Group on 800
Coleman Research Group on Blogspot
Coleman Research Group on Jobster
Coleman Research Group's Knowledge Broker

Coleman Research Group’s Business and Financial Services Group highlights New Bank Stress Tests and Chrysler's Sale to Fiat

Coleman Research Group’s Business and Financial Services Group facilitates consultations between our clients (institutional investors) and leading business and financial services professionals on a wide variety of topics including consumer credit trends, banking and investment services, insurance, residential and commercial real estate, student lending, and regulatory issues.

Our Business & Financial network includes an elite assembly of current and former CFOs and senior executives, accountants, former regulatory officials, academics, and top-level industry consultants.

********************************

Oversight Panel Pushes for New Bank Stress Tests

The stress tests conducted on the largest U.S. banks should be repeated with updated figures, The Congressional Oversight Panel said.

The committee headed by Harvard Law School professor Elizabeth Warren, which oversees the $700 billion financial bailout package passed in October, said the stress tests ordered by the U.S. Treasury, evaluated banks' health against the possibility of unemployment rising to 8.9 percent. In May, the Department of Labor said unemployment exceeded that, rising to 9.4 percent, calling the results into question, a report to be released Tuesday said.

The panel said the stress tests were helpful, but lacked transparency on how they were conducted, The Washington Post reported.

********************************

Supreme Court Temporarily Blocks Chrysler Sale to Fiat

The U.S. Supreme Court on Monday temporarily blocked the sale of Chrysler LLC's assets to a new partnership with Fiat SpA, the first unexpected delay in the automaker's bankruptcy stage-managed by the Obama administration.

The one-page order by Supreme Court Justice Ruth Bader Ginsburg stopped the sale "pending further order" by her or the full court, based on an appeal by three Indiana pension funds holding $45 million in Chrysler's secured loans. Ginsburg gave no time frame for when those next orders might arrive.

********************************

To learn more about Coleman Research Group please visit the Coleman Research Group website or at any of the links below:

About Coleman Research Group
Coleman Research Group Testimonials
Coleman Research Group on LinkedIn
Coleman Research Group on Facebook
Coleman Research Group on Flickr
Coleman Research Group on Squidoo
Coleman Research Group on Namyz
Coleman Research Group on Twitter
Coleman Research Group on Review-Inc
Coleman Research Group Contact Us
Coleman Research Group on 800
Coleman Research Group on Blogspot
Coleman Research Group on Jobster
Coleman Research Group's Knowledge Broker

Coleman Research Group’s Healthcare department highlights Sky-High Calories in Some Restaurant Meals and Vaccine Fights Melanoma

Coleman Research Group’s Healthcare Team facilitates consultations between our clients (institutional investors) and leading healthcare professionals on a wide variety of topics including pharmaceuticals, biotechnology, clinical research, medical devices, healthcare providers, insurance, and regulatory issues.

Our Healthcare network spans technology industries across the globe and includes doctors, researchers, scientists, healthcare executives, consultants, and former regulatory officials.

********************************

Sky-High Calories in Some Restaurant Meals
June 2, 2009

June 2, 2009 -- Restaurants are serving ever-larger portions of super-bad food to entice customers to start eating out again, according to a consumer watchdog group.

In a list of the most over-the-top, unhealthy restaurant foods, the Center for Science in the Public Interest singled out some dishes that provide more saturated fat or sodium than most people should eat in three days. The foods were also high in calories.

U.S. dietary guidelines call for healthy Americans to get less than 2,300 milligrams of sodium a day, about the amount in a teaspoon of table salt, to lower blood pressure and reduce risk of heart disease, stroke, heart failure, and kidney disease. But for the 70% of Americans who are middle-aged or older, African-American, or have high blood pressure, no more than 1,500 milligrams a day is recommended.

********************************

Vaccine Fights Melanoma
June 2, 2009

June 1, 2009 (Orlando) -- For the first time, a vaccine that trains the immune system to seek out and attack cancer cells has been shown to shrink tumors in people with melanoma.

In a study of 185 melanoma patients, the experimental vaccine also extended the time that people remained free of cancer.

There are even indications that people given the vaccine live longer, but patients need to be followed longer before researchers can be sure, says Patrick Hwu, MD, head of melanoma medical oncology at the University of Texas M.D. Anderson Cancer Center in Houston.

********************************

To learn more about Coleman Research Group please visit the Coleman Research Group website or at any of the links below:


About Coleman Research Group
Coleman Research Group Testimonials
Coleman Research Group on LinkedIn
Coleman Research Group on Facebook
Coleman Research Group on Flickr
Coleman Research Group on Squidoo
Coleman Research Group on Namyz
Coleman Research Group on Twitter
Coleman Research Group on Review-Inc
Coleman Research Group Contact Us
Coleman Research Group on 800 Review
Coleman Research Group on Blogspot
Coleman Research Group on Jobster
Coleman Research Group's Knowledge Broker

Coleman Research Group’s Healthcare department highlights Prevention Of Blood Clots and Children With Autism

Coleman Research Group’s Healthcare Team facilitates consultations between our clients (institutional investors) and leading healthcare professionals on a wide variety of topics including pharmaceuticals, biotechnology, clinical research, medical devices, healthcare providers, insurance, and regulatory issues.

Our Healthcare network spans technology industries across the globe and includes doctors, researchers, scientists, healthcare executives, consultants, and former regulatory officials.

********************************

Silver Nanoparticles Show 'Immense Potential' In Prevention Of Blood Clots
June 2, 2009

Scientists are reporting discovery of a potential new alternative to aspirin, ReoPro, and other anti-platelet agents used widely to prevent blood clots in coronary artery disease, heart attack and stroke. Their study involves particles of silver — 1/50,000th the diameter of a human hair — that are injected into the bloodstream.

Debabrata Dash and colleagues point out that patients urgently need new anti-thrombotic agents because traditionally prescribed medications too-often cause dangerous bleeding. At the same time, aging of the population, sedentary lifestyle and spiraling rates of certain diseases have increased the use of these drugs. Researchers are seeking treatments that more gently orchestrate activity of platelets, disk-shaped particles in the blood that form clots.

********************************

Citalopram No Better Than Placebo Treatment For Children With Autism Spectrum Disorders
June 2, 2009

Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.

"Parents of children with autism spectrum disorders face an enormous number of treatment options, not all of which are research-based," said NIMH Director Thomas R. Insel, M.D. "Studies like this help us to better understand which treatments are likely to be beneficial and safe."

The researchers say their findings do not support using citalopram to treat repetitive behaviors in children with ASD. Also, the greater frequency of side effects from this particular medication compared to placebo illustrates the importance of placebo-controlled trials in evaluating medications currently prescribed to this population.

********************************

To learn more about Coleman Research Group please visit the Coleman Research Group website or at any of the links below:


About Coleman Research Group
Coleman Research Group Testimonials
Coleman Research Group on LinkedIn
Coleman Research Group on Facebook
Coleman Research Group on Flickr
Coleman Research Group on Squidoo
Coleman Research Group on Namyz
Coleman Research Group on Twitter
Coleman Research Group on Review-Inc
Coleman Research Group Contact Us
Coleman Research Group on 800 Review
Coleman Research Group on Blogspot
Coleman Research Group on Jobster
Coleman Research Group's Knowledge Broker

Coleman Research Group’s Business and Financial Services Group highlights the Chinese Acquisition of Hummer and Bank of America

Coleman Research Group’s Business and Financial Services Group facilitates consultations between our clients (institutional investors) and leading business and financial services professionals on a wide variety of topics including consumer credit trends, banking and investment services, insurance, residential and commercial real estate, student lending, and regulatory issues.

Our Business & Financial network includes an elite assembly of current and former CFOs and senior executives, accountants, former regulatory officials, academics, and top-level industry consultants.

********************************

The Chinese give Tim Geithner a warm welcome - to a point
June 2, 2009

BEIJING (Fortune) -- When the Treasury Secretary met with leaders in Beijing to offer assurances that the U.S. can repay its debts, he received a somewhat sympathetic ear.

China, which has nearly $800 billion of its savings invested in U.S. government securities, has publicly and privately been lecturing Washington on its profligate fiscal policy. So it was no surprise when Tim Geithner made his maiden journey to China as Treasury Secretary that he faced some heat. Yesterday, in fact, Chinese students laughed out loud when Geithner reassured one questioner that their country's investments in the US are "very safe."

********************************

BofA close to stress test capital target
June 2, 2009

NEW YORK (CNNMoney.com) -- Bank of America revealed Tuesday that it was nearly finished raising the $33.9 billion in capital that industry regulators deemed it needed to shield itself from future losses.

The nation's biggest lender by assets said it had raised almost $33 billion since the government announced the results of its so-called stress test for 19 of the nation's largest banks nearly a month ago.

"We are pleased to have nearly reached our goal this quickly," Joe Price, Bank of America's chief financial officer said in a statement.

********************************

To learn more about Coleman Research Group please visit the Coleman Research Group website or at any of the links below:

About Coleman Research Group
Coleman Research Group Testimonials
Coleman Research Group on LinkedIn
Coleman Research Group on Facebook
Coleman Research Group on Flickr
Coleman Research Group on Squidoo
Coleman Research Group on Namyz
Coleman Research Group on Twitter
Coleman Research Group on Review-Inc
Coleman Research Group Contact Us
Coleman Research Group on 800
Coleman Research Group on Blogspot
Coleman Research Group on Jobster
Coleman Research Group's Knowledge Broker